We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Rsh5.0
Rosehip Research
Mostly mechanism / observational
16 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Rosehip studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2004–2026 with a typical study size of 120 participants.
Based on 16 studies · 1 meta-analysis · 8 RCTs · 120 total participants
Confidence
Moderate confidence
By outcome
Joint pain & arthritisSmall-to-moderate reduction in osteoarthritis pain (meta-analysis effect size ~0.37; NNT ~6) with reduced rescue-analgesic use · 3 weeks to 3 months
Mostly mechanism / observational8 studies
Steady research
2 studies in the last 5 years · Latest meta-analysis: 2008
200420152026
1Meta-Analysis2008
Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H · Osteoarthritis Cartilage (2008)
In plain English: Incorporating such analyses could improve the identification of nutrients containing biologically active preparations and support dose selection in future clinical research.
Motawei AM, Warholm KM, Winther K. · Nutrients (2026)
Results Both groups showed significant improvement, over 50%, with no statistically significant differences between them in WOMAC pain or function.
Conclusions Dose-response correlation analysis uncovered positive effects of Rosa-canina as a nutrient that were not detectable through standard between-group comparisons.
This is consistent with findings from earlier rose-hip research.
In plain English: The objective is to critically evaluate the existing evidence to assess the potential for developing functional foods and therapeutic products based on rosehips.
Mao Q, Zhou M, Lei L, Zhang Y, Chen H, Zhu B, Luo L, Yu C. · Journal of agricultural and food chemistry (2026)
However, research on rosehips remains scattered, with limited systematic integration of their ethnomedicinal uses, bioactive compounds, and therapeutic potentials.
This review critically synthesizes recent advances in the identification of rosehip bioactive compounds, their pharmacological activities, traditional medicinal applications, and available clinical safety evidence.
The review also identifies the primary constraints affecting the broader application of rosehips, including inefficient resource utilization, fragmented evidence, limited clinical validation, and weak commercialization pathways.
In plain English: In both double-blind randomized studies, rosehip powder had a moderate effect in patients with osteoarthritis.
Rossnagel K, Roll S, Willich SN · MMW Fortschr Med (2007)
Systematic review of two double-blind RCTs (N=100 and 112, Jadad score 5)
One trial significantly improved hip flexion; another showed 66% vs 35% reporting pain reduction at 3 months (p<0.013)
No significant difference in analgesic consumption in one trial
16Review2012
In plain English: Standardised rosehip powder consistently reduced pain scores and patients were twice as likely to respond compared to placebo, without the ulcerogenic effects of NSAIDs.
Cohen M · Aust Fam Physician (2012)
Reviews the meta-analysis of three RCTs (287 patients)
Notes anti-inflammatory action without platelet/coagulation effects, unlike NSAIDs and aspirin
Galactolipid identified as the specific anti-inflammatory constituent